Coda Biotherapeutics is a preclinical-stage biopharmaceutical company pioneering a new generation of targeted gene therapies for neurological disorders. They are leveraging their proprietary chemogenetic platform to develop treatments that enable precise, reversible, and titratable control of neuronal activity. Coda's primary focus is on developing therapies for focal epilepsy and neuropathic pain, aiming to provide durable and tunable relief for patients with these debilitating conditions.
Serves as the central hub for research and development, corporate operations, and strategic planning for its novel gene therapy programs.
Located within a prominent biotech campus, providing access to state-of-the-art laboratory facilities and a collaborative research environment.
A dynamic and science-driven environment focused on innovation, collaboration, and addressing unmet medical needs in neurology. Employees are typically passionate about advancing gene therapy and making a difference in patients' lives.
Its location in South San Francisco places Coda Biotherapeutics at the epicenter of the biotech industry, fostering collaborations, talent acquisition, and access to a rich ecosystem of research institutions and investors.
Coda Biotherapeutics is currently focused on preclinical development and research primarily conducted from its US headquarters. While its therapeutic ambitions have global implications for patients with neurological disorders, its operational presence is concentrated in the United States. Future global expansion may occur as its programs advance through clinical trials and towards commercialization.
611 Gateway Blvd, Suite 215
South San Francisco
CA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Coda Biotherapeutics' leadership includes:
Coda Biotherapeutics has been backed by several prominent investors over the years, including:
In the past 12 months, Coda Biotherapeutics strengthened its technical operations leadership with a key SVP hire. No major C-suite departures have been publicly announced during this period.
Discover the tools Coda Biotherapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Common email formats for Coda Biotherapeutics likely follow standard professional patterns. One of the most probable formats uses the first initial followed by the last name.
[first_initial][last]@codabio.com
Format
mnarachi@codabio.com
Example
75%
Success rate
GlobeNewswire • November 7, 2023
Coda Biotherapeutics announced the presentation of preclinical data highlighting the potential of its chemogenetic gene therapy platform in selectively and reversibly modulating neuronal activity for neurological disorders. The data were shared at the Society for Neuroscience (SfN) 2023 annual meeting....more
GlobeNewswire • May 17, 2023
Coda Biotherapeutics presented promising preclinical data for its focal epilepsy gene therapy program at the American Society of Gene & Cell Therapy (ASGCT) 26th Annual Meeting. The findings demonstrated the potential for durable, titratable seizure control....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Coda Biotherapeutics, are just a search away.